ZEPP
Income statement / Annual
Last year (2023), Zepp Health Corporation's total revenue was $2.50 B,
a decrease of 39.77% from the previous year.
In 2023, Zepp Health Corporation's net income was -$212.12 M.
See Zepp Health Corporation’s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
| Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
| Operating Revenue |
$2.50 B
|
$4.14 B
|
$6.25 B
|
$6.43 B
|
$5.81 B
|
$3.65 B
|
$2.05 B
|
$1.56 B
|
$896.46 M
|
| Cost of Revenue |
$1.84 B |
$3.34 B |
$4.94 B |
$5.10 B |
$4.34 B |
$2.71 B |
$1.55 B |
$1.28 B |
$785.87 M |
| Gross Profit |
$657.78 M |
$803.12 M |
$1.31 B |
$1.33 B |
$1.47 B |
$939.45 M |
$494.70 M |
$276.15 M |
$110.59 M |
| Gross Profit Ratio |
0.26 |
0.19 |
0.21 |
0.21 |
0.25 |
0.26 |
0.24 |
0.18 |
0.12 |
| Research and Development
Expenses |
$361.81 M
|
$517.12 M
|
$515.08 M
|
$538.01 M
|
$430.82 M
|
$263.22 M
|
$153.83 M
|
$132.30 M
|
$61.55 M
|
| General & Administrative
Expenses |
$188.51 M
|
$235.93 M
|
$258.35 M
|
$261.81 M
|
$248.46 M
|
$213.97 M
|
$114.88 M
|
$102.64 M
|
$69.98 M
|
| Selling & Marketing
Expenses |
$314.56 M
|
$460.30 M
|
$438.27 M
|
$358.66 M
|
$181.98 M
|
$96.54 M
|
$44.03 M
|
$27.82 M
|
$19.17 M
|
| Selling, General &
Administrative Expenses |
$503.07 M
|
$696.24 M
|
$696.62 M
|
$620.46 M
|
$430.44 M
|
$310.51 M
|
$158.91 M
|
$130.47 M
|
$89.15 M
|
| Other Expenses |
$0.00 |
$43.82 M |
$40.93 M |
-$23.55 M |
$10.59 M |
$1.18 M |
$4.56 M |
$14.73 M |
$1.11 M |
| Operating Expenses |
$864.88 M |
$1.21 B |
$1.21 B |
$1.16 B |
$861.26 M |
$573.73 M |
$312.73 M |
$262.77 M |
$150.71 M |
| Cost And Expenses |
$2.70 B |
$4.55 B |
$6.16 B |
$6.26 B |
$5.21 B |
$3.28 B |
$1.87 B |
$1.54 B |
$936.57 M |
| Interest Income |
$3.09 M |
$12.33 M |
$16.69 M |
$46.12 M |
$33.48 M |
$11.60 M |
$3.00 M |
$754,000.00 |
$255,000.00 |
| Interest Expense |
$6.73 M |
$57.00 M |
$44.88 M |
$22.62 M |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Depreciation &
Amortization |
$54.45 M
|
$58.62 M
|
$51.88 M
|
$27.13 M
|
$17.22 M
|
$6.22 M
|
$3.72 M
|
$2.40 M
|
$285,000.00
|
| EBITDA |
-$134.39 M
|
-$354.09 M
|
$93.94 M
|
$105.35 M
|
$623.70 M
|
$357.60 M
|
$185.69 M
|
$15.78 M
|
-$39.83 M
|
| EBITDA Ratio |
-0.05 |
-0.09 |
0.02 |
0.02 |
0.1 |
0.1 |
0.09 |
0.01 |
-0.04 |
| Operating Income Ratio
|
-0.08
|
-0.1
|
0.02
|
0.01
|
0.1
|
0.1
|
0.09
|
0.01
|
-0.04
|
| Total Other
Income/Expenses Net |
$173.70 M
|
$356.25 M
|
-$77.21 M
|
-$37.57 M
|
-$513.25 M
|
-$309.52 M
|
-$152.58 M
|
$15.48 M
|
$1.36 M
|
| Income Before Tax |
-$33.40 M |
-$372.53 M |
$106.67 M |
$265.61 M |
$652.37 M |
$386.61 M |
$191.90 M |
$28.86 M |
-$38.75 M |
| Income Before Tax Ratio
|
-0.01
|
-0.09
|
0.02
|
0.04
|
0.11
|
0.11
|
0.09
|
0.02
|
-0.04
|
| Income Tax Expense |
-$15.82 M |
-$65.88 M |
$10.75 M |
$31.15 M |
$77.89 M |
$52.04 M |
$27.61 M |
$3.09 M |
-$897,000.00 |
| Net Income |
-$212.12 M |
-$306.66 M |
$95.92 M |
$228.75 M |
$575.20 M |
$340.05 M |
$167.68 M |
$23.95 M |
-$37.85 M |
| Net Income Ratio |
-0.09 |
-0.07 |
0.02 |
0.04 |
0.1 |
0.09 |
0.08 |
0.02 |
-0.04 |
| EPS |
-13.96 |
-4.98 |
1.52 |
3.68 |
9.44 |
6.08 |
0.78 |
-0.2 |
-0.64 |
| EPS Diluted |
-13.96 |
-4.98 |
1.45 |
3.51 |
8.99 |
6.04 |
0.78 |
-0.2 |
-0.64 |
| Weighted Average Shares
Out |
$15.20 M
|
$61.57 M
|
$63.04 M
|
$62.12 M
|
$60.91 M
|
$55.94 M
|
$59.43 M
|
$59.43 M
|
$59.43 M
|
| Weighted Average Shares
Out Diluted |
$15.20 M
|
$61.57 M
|
$66.09 M
|
$65.09 M
|
$63.99 M
|
$56.26 M
|
$59.43 M
|
$59.43 M
|
$59.43 M
|
| Link |
|
|
|
|
|
|
|
|
|
